| 臺大學術典藏 |
2020-02-24T01:34:00Z |
Favorable results of concomitant tacrolimus and sirolimus therapy in Taiwanese renal transplant recipients at 12 months
|
Lee P.-H.;REY-HENG HU;Wu F.-L.L.;Lai I.-R.;Tsai M.-K.;Chen K.-H.; Chen K.-H.; Tsai M.-K.; Lai I.-R.; Wu F.-L.L.; REY-HENG HU; Lee P.-H. |
| 臺大學術典藏 |
2020-02-24T01:33:46Z |
De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor
|
Chen K.-H.;Lee C.-Y.;Wu F.L.L.;Yang C.-Y.;Yeh C.-C.;Rey-Heng Hu;Tsai M.-K.; Chen K.-H.; Lee C.-Y.; Wu F.L.L.; Yang C.-Y.; Yeh C.-C.; REY-HENG HU; Tsai M.-K. |
| 臺大學術典藏 |
2020-02-20T02:56:59Z |
De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor
|
Chen K.-H.;Lee C.-Y.;Wu F.L.L.;Ching-Yao Yang;Yeh C.-C.;Hu R.-H.;Tsai M.-K.; Chen K.-H.; Lee C.-Y.; Wu F.L.L.; CHING-YAO YANG; Yeh C.-C.; Hu R.-H.; Tsai M.-K. |
| 臺大學術典藏 |
2020-02-14T02:49:40Z |
Prognostic factors in epithelial ovarian cancer: A population-based study
|
Chang L.-C.;Huang C.-F.;Lai M.-S.;Shen L.-J.;Wu F.-L.L.;Wen-Fang Cheng; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; Wu F.-L.L.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-06T05:21:50Z |
Prognostic factors in epithelial ovarian cancer: A population-based study
|
WEN-FANG CHENG;Wu F.-L.L.;Shen L.-J.;Lai M.-S.;Huang C.-F.;Chang L.-C.; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; Wu F.-L.L.; WEN-FANG CHENG; Chang L.-C.; Huang C.-F.; Lai M.-S.; Shen L.-J.; Wu F.-L.L.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020 |
Pharmacokinetics and dosing of vancomycin in patients undergoing sustained low efficiency daily diafiltration (SLEDD-f): A prospective study
|
Wu C.-C.; Wu F.-L.L.; Ko W.-J.; Shen L.-J.; Lin S.-Y. |
| 臺大學術典藏 |
2019-12-04T02:00:14Z |
The influence of sampling time on sirolimus trough concentrations
|
Lee P.-H.; Yu W.-Y.; Sun S.-W.; MENG-KUN TSAI; Wu F.-L.L.; Wu F.-L.L.;Meng-Kun Tsai;Sun S.-W.;Yu W.-Y.;Lee P.-H. |
| 臺大學術典藏 |
2019-12-04T02:00:12Z |
Effects of conversion from sirolimus oral solution to tablets in stable Taiwanese renal transplant recipients
|
Huang J.-D.; Lee P.-H.; Sun S.-W.; Chen R.R.-L.; MENG-KUN TSAI; Wu F.-L.L.;Meng-Kun Tsai;Sun S.-W.;Chen R.R.-L.;Huang J.-D.;Lee P.-H.; Wu F.-L.L. |
| 臺大學術典藏 |
2019-12-04T02:00:12Z |
Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients
|
Wu F.-L.L.;Meng-Kun Tsai;Rhei-Long Chen R.;Sun S.-W.;Huang J.-D.;Hu R.-H.;Chen K.-H.;Lee P.-H.; Wu F.-L.L.; MENG-KUN TSAI; Rhei-Long Chen R.; Sun S.-W.; Huang J.-D.; Hu R.-H.; Chen K.-H.; Lee P.-H. |
| 臺大學術典藏 |
2019-12-04T02:00:10Z |
Favorable results of concomitant tacrolimus and sirolimus therapy in Taiwanese renal transplant recipients at 12 months
|
Hu R.-H.; Lee P.-H.; Lee P.-H.;Hu R.-H.;Wu F.-L.L.;Lai I.-R.;MENG-KUN TSAI;Chen K.-H.; Chen K.-H.; MENG-KUN TSAI; Lai I.-R.; Wu F.-L.L. |
| 臺大學術典藏 |
2019-12-04T02:00:01Z |
De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor
|
Chen K.-H.;Lee C.-Y.;Wu F.L.L.;Yang C.-Y.;Yeh C.-C.;Hu R.-H.;Meng-Kun Tsai; Chen K.-H.; Lee C.-Y.; Wu F.L.L.; Yang C.-Y.; Yeh C.-C.; Hu R.-H.; MENG-KUN TSAI |
| 臺大學術典藏 |
2018-09-10T18:02:52Z |
Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
|
Hu, M.-M. ; Wang, J. ; Chien, K.-L. ; Su, C.-L. ; Lin, S.-Y. ; Wu, F.-L.L. ; Lin, Z.-F.; ZHEN-FANG LIN; Shin Yi Lin; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2018-09-10T15:37:04Z |
Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis
|
Lo, Y.;Shen, L.-J.;Chen, W.-H.;Dong, Y.-H.;Wu, F.-L.L.; LI-JIUAN SHEN; Lo, Yin; Shen, Li-Jiuan; Chen, Wen-Hwei; Dong, Yaa-Hui; Wu, Fe-Lin Lin |
| 臺大學術典藏 |
2018-09-10T15:26:47Z |
A larger dose of vancomycin is required in adult neurosurgical intensive care unit patients due to augmented clearance
|
Wu, F.-L.L.;Liu, S.-S.;Yang, T.-Y.;Win, M.-F.;Lin, S.-W.;Huang, C.-F.;Wang, K.-C.;Shen, L.-J.; LI-JIUAN SHEN |
| 臺大學術典藏 |
2018-09-10T15:26:47Z |
Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker/thiazide diuretics among newly diagnosed hypertensive patients: A population-based cohort study
|
林慧玲;蕭斐元;沈麗娟; Hsu, C.-I.;Hsiao, F.-Y.;Wu, F.-L.L.;Shen, L.-J.; LI-JIUAN SHEN; Hsu, C. -I.; Hsiao, F. -Y.; Wu, F. -L. L.; Shen, L. -J.; 林慧玲; 蕭斐元 |
| 臺大學術典藏 |
2018-09-10T09:40:40Z |
Beyond-use date of extemporaneous morphine hydrochloride oral solution
|
Lin, C.-Y.;Shen, L.-J.;Huang, C.-F.;Yang, H.-L.;Chen, Y.-J.;Wu, F.-L.L.; LI-JIUAN SHEN; FE-LIN LIN WU |
| 臺大學術典藏 |
2018-09-10T09:14:46Z |
Are brand-name drugs of better quality than generics? Research at a Medical Center in Taiwan
|
Yang, H.-L.;Shen, L.-J.;Huang, C.-F.;Lin, C.-Y.;Chen, W.-H.;Hsieh, Y.-T.;Wu, F.-L.L.; LI-JIUAN SHEN |
| 臺大學術典藏 |
2018-09-10T07:22:55Z |
Analysis of human resource requirements in an adverse drug reaction evaluation consultation service
|
Wu, F.-L.L.;Souney, P.F.;Rossiter, A.; FE-LIN LIN WU |
| 臺大學術典藏 |
2018-09-10T07:22:55Z |
Stability of extemporaneous suspensions of co-trimoxazole+
|
Wu, F.-L.L.;Shen, L.-J.;Yang, C.-C.;Chen, C.-H.; FE-LIN LIN WU |
| 臺大學術典藏 |
2018-09-10T07:22:54Z |
Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy
|
Tsai, M.-K.;Wu, F.-L.L.;Lai, I.-R.;Lee, C.-Y.;Hu, R.-H.;Lee, P.-H.; FE-LIN LIN WU |
| 臺大學術典藏 |
2018-09-10T07:22:37Z |
Stability of extemporaneous suspensions of co-trimoxazole+
|
Wu, F.-L.L.;Shen, L.-J.;Yang, C.-C.;Chen, C.-H.; LI-JIUAN SHEN |
| 臺大學術典藏 |
2018-09-10T06:50:51Z |
Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia
|
Yu, H.-H.;Wu, F.-L.L.;Lin, S.-E.;Shen, L.-J.Yu, Hao-Hsin;Wu, Fe-Lin Lin;Lin, Shan-Erh;Shen, Li-Jiuan; Yu, Hao-Hsin; LI-JIUAN SHEN; FE-LIN LIN WU; Wu, Fe-Lin Lin; Lin, Shan-Erh; Shen, Li-Jiuan |
| 臺大學術典藏 |
2018-09-10T06:15:29Z |
Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan
|
Gau, C.-S.;Chang, I.-S.;Wu, F.-L.L.;Yu, H.-T.;Huang, Y.-W.;Chi, C.-L.;Chien, S.-Y.;Lin, K.-M.;Liu, M.-Y.;Wang, H.-P.; FE-LIN LIN WU |
| 臺大學術典藏 |
2018-09-10T06:15:28Z |
Effects of a national medication education program in Taiwan to change the public's perceptions of the roles and functions of pharmacists
|
Wen, M.F.;Lin, S.-J.;Yang, Y.-H.K.;Huang, Y.-M.;Wang, H.-P.;Chen, C.-S.;Wu, F.-L.L.; FE-LIN LIN WU |
| 臺大學術典藏 |
2018-09-10T05:47:14Z |
Therapeutic Drug Monitoring of Cyclosporine Neoral in de Novo Chinese Cardiac Transplant Recipients Treated with an Everolimus-Cyclosporine Immunosuppressive Regimen
|
Wang, C.-H.;Chou, N.-K.;Wu, F.-L.L.;Ko, W.-J.;Tsao, C.-I.;Chi, N.-H.;Hsu, R.-B.;Wang, S.-S.; CHIH-HSIEN WANG; Nai-Kuan Chou; SHOEI-SHEN WANG; NAI-HSIN CHI; FE-LIN LIN WU |
